Aristeia Capital’s Esperion Therapeutics ESPR Stock Holding History

Aristeia Capital’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-70,959	Closed	-$102K	–	523
2025 Q1	$102K	Hold	70,959	–	–	﹤0.01%	337
2024 Q4	$156K	Hold	70,959	–	–	0.01%	284
2024 Q3	$117K	Hold	70,959	–	–	﹤0.01%	253
2024 Q2	$158K	Hold	70,959	–	–	﹤0.01%	226
2024 Q1	$190K	Hold	70,959	–	–	﹤0.01%	172
2023 Q4	$212K	Hold	70,959	–	–	﹤0.01%	83
2023 Q3	$69.5K	Hold	70,959	–	–	﹤0.01%	127
2023 Q2	$98.6K	Hold	70,959	–	–	﹤0.01%	143
2023 Q1	$113K	Hold	70,959	–	–	﹤0.01%	231
2022 Q4	$442K	Sell	70,959 -44,992	-39%	-$322K	0.01%	323
2022 Q3	$777K	Hold	115,951	–	–	0.01%	406
2022 Q2	$737K	Hold	115,951	–	–	0.01%	381
2022 Q1	$538K	Hold	115,951	–	–	0.01%	396
2021 Q4	$580K	Buy	115,951 +48,258	+71%	+$386K	0.01%	429
2021 Q3	$816K	Buy	+67,693	New	+$986K	0.02%	354

Other funds holding ESPR

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return

PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return